Free for academic non-profit institutions. Other users need a Commercial license
The protein encoded by this gene acts as a transcriptional coactivator for steroid and nuclear hormone receptors. It is a member of the p160/steroid receptor coactivator (SRC) family and like other family members has histone acetyltransferase activity and contains a nuclear localization signal, as well as bHLH and PAS domains. The product of this gene binds nuclear receptors directly and stimulates the transcriptional activities in a hormone-dependent fashion. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
NCOA1 (Nuclear Receptor Coactivator 1) is a Protein Coding gene. Diseases associated with NCOA1 include Rhabdomyosarcoma and Endometrial Hyperplasia. Among its related pathways are Transcription Androgen Receptor nuclear signaling and Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha). Gene Ontology (GO) annotations related to this gene include chromatin binding and transcription factor binding. An important paralog of this gene is NCOA2.
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | ISM | 19274049 |
GO:0001012 | RNA polymerase II regulatory region DNA binding | IEA | -- |
GO:0003677 | DNA binding | IEA | -- |
GO:0003682 | chromatin binding | IEA | -- |
GO:0003713 | transcription coactivator activity | NAS | 15572661 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000790 | nuclear chromatin | IDA | 15831516 |
GO:0005634 | nucleus | IBA | 21873635 |
GO:0005654 | nucleoplasm | TAS | -- |
GO:0005737 | cytoplasm | IEA | -- |
GO:0005829 | cytosol | IDA | -- |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | Synthesis of bile acids and bile salts | ||
2 | Cytochrome P450 - arranged by substrate type | ||
3 | BMAL1-CLOCK,NPAS2 activates circadian gene expression |
.68
|
|
4 | Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | ||
5 | RNA Polymerase II Transcription Initiation And Promoter Clearance |
Protein Acetylation and Deacetylation
.51
Crosstalk Between CARM1 and ESRs
.39
|
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000435 | positive regulation of transcription from RNA polymerase II promoter by galactose | IDA | 10207113 |
GO:0002155 | regulation of thyroid hormone mediated signaling pathway | IEA | -- |
GO:0006351 | transcription, DNA-templated | IDA | 9223431 |
GO:0006355 | regulation of transcription, DNA-templated | IEA | -- |
GO:0007595 | lactation | IEA | -- |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Tamoxifen | Approved | Pharma | Antagonist | TGF-β modulatory and PKC inhibitory effects, ER antagonist, Anti-Estrogens | 446 | |
Corticosterone | Experimental | Pharma | Target | 16 | ||
(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol | Experimental | Pharma | Target | 0 | ||
(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID | Experimental | Pharma | Target | 0 | ||
(5BETA)-PREGNANE-3,20-DIONE | Experimental | Pharma | Target | 0 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs | |
---|---|---|---|---|---|---|
acetyl-coa |
|
72-89-9 |
|
ExUns: | 1 | ^ | 2 | ^ | 3a | · | 3b | ^ | 4 | ^ | 5 | ^ | 6 | ^ | 7 | ^ | 8 | ^ | 9 | ^ | 10 | ^ | 11 | ^ | 12 | ^ | 13 | ^ | 14 | ^ | 15 | ^ | 16 | ^ | 17 | ^ | 18 | ^ | 19 | ^ | 20 | ^ | 21a | · | 21b | ^ | 22a | · | 22b |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SP1: | - | - | - | ||||||||||||||||||||||||||||||||||||||||||||||
SP2: | - | - | |||||||||||||||||||||||||||||||||||||||||||||||
SP3: | - | - | - | ||||||||||||||||||||||||||||||||||||||||||||||
SP4: | - | ||||||||||||||||||||||||||||||||||||||||||||||||
SP5: | |||||||||||||||||||||||||||||||||||||||||||||||||
SP6: |
This gene was present in the common ancestor of chordates.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
chimpanzee (Pan troglodytes) |
Mammalia | NCOA1 33 32 |
|
OneToOne | |
dog (Canis familiaris) |
Mammalia | NCOA1 33 32 |
|
OneToOne | |
cow (Bos Taurus) |
Mammalia | NCOA1 33 32 |
|
OneToOne | |
rat (Rattus norvegicus) |
Mammalia | Ncoa1 32 |
|
||
mouse (Mus musculus) |
Mammalia | Ncoa1 17 33 32 |
|
||
oppossum (Monodelphis domestica) |
Mammalia | NCOA1 33 |
|
OneToOne | |
platypus (Ornithorhynchus anatinus) |
Mammalia | NCOA1 33 |
|
OneToOne | |
chicken (Gallus gallus) |
Aves | NCOA1 33 32 |
|
OneToOne | |
lizard (Anolis carolinensis) |
Reptilia | NCOA1 33 |
|
OneToOne | |
tropical clawed frog (Silurana tropicalis) |
Amphibia | ncoa1 32 |
|
||
zebrafish (Danio rerio) |
Actinopterygii | ncoa1 33 |
|
OneToOne |
SNP ID | Clin | Chr 02 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
rs1000007042 | -- | 24,720,902(+) | C/T | intron_variant | |
rs1000035282 | -- | 24,636,889(+) | G/A | intron_variant | |
rs1000050691 | -- | 24,541,230(+) | T/C | genic_upstream_transcript_variant, intron_variant | |
rs1000064433 | -- | 24,547,610(+) | T/C | genic_upstream_transcript_variant, intron_variant | |
rs1000102313 | -- | 24,668,168(+) | A/G | intron_variant |
Variant ID | Type | Subtype | PubMed ID |
---|---|---|---|
esv1430695 | CNV | deletion | 17803354 |
esv2719821 | CNV | deletion | 23290073 |
esv3590074 | CNV | loss | 21293372 |
esv3590076 | CNV | loss | 21293372 |
nsv1000020 | CNV | gain | 25217958 |
nsv1004529 | CNV | loss | 25217958 |
nsv1143934 | CNV | deletion | 24896259 |
nsv2643 | CNV | insertion | 18451855 |
nsv516493 | CNV | gain | 19592680 |
nsv528864 | CNV | loss | 19592680 |
nsv997725 | CNV | gain | 25217958 |
Disorder | Aliases | PubMed IDs |
---|---|---|
rhabdomyosarcoma |
|
|
endometrial hyperplasia |
|
|
amelogenesis imperfecta, type ig |
|
|
breast cancer |
|